Showing results (101-110 of 172) with videos related to

Sort By:
Pageof 18
International Journal of Bipolar Disorders|February 10, 2016
Harnessing the potential of community-based participatory research approaches in bipolar disorderErin E Michalak, Steven Jones, Fiona Lobban, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 9, 2020
Structural covariance pattern abnormalities of insula in major depressive disorder: A CAN-BIND study reportRuiyang Ge, Stefanie Hassel, Stephen R Arnott, et al.
Neuroimage. Clinical|July 31, 2022
Predicting escitalopram treatment response from pre-treatment and early response resting state fMRI in a multi-site sample: A CAN-BIND-1 reportJacqueline K Harris, Stefanie Hassel, Andrew D Davis, et al.
CNS Spectrums|May 23, 2023
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 reportM Ishrat Husain, Jane A Foster, Brittany L Mason, et al.
Bipolar Disorders|June 15, 2005
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversiesLakshmi N Yatham, Sidney H Kennedy, Claire O'Donovan, et al.
Psychiatry Research|November 18, 2023
Predicting recurrence of major depressive episodes using the Depression Implicit Association Test: A Canadian biomarker integration network in depression (CAN-BIND) reportKaterina Rnic, Joelle LeMoult, Ivan J Torres, et al.
BMC Psychiatry|June 4, 2020
A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocolJennifer L Phillips, Natalia Jaworska, Elizabeth Kamler, et al.
Cerebellum (London, England)|January 13, 2022
Cerebello-cerebral Functional Connectivity Networks in Major Depressive Disorder: a CAN-BIND-1 Study ReportSheeba Arnold Anteraper, Xavier Guell, Yoon Ji Lee, et al.
Translational Psychiatry|August 22, 2021
Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant responseLaura M Fiori, Massimiliano Orri, Zahia Aouabed, et al.
Pharmacopsychiatry|July 6, 2022
Identification of Endocannabinoid Predictors of Treatment Outcomes in Major Depressive Disorder: A Secondary Analysis of the First Canadian Biomarker Integration Network in Depression (CAN-BIND 1) StudyHelena K Kim, Gwyneth Zai, Daniel J Müller, et al.
Pageof 18